214 related articles for article (PubMed ID: 31383839)
1. Development of Human Leukocyte Antigen (HLA) Antibodies Against Vascular Homograft Donor in Pediatric Heart Transplant Recipients.
Jahnukainen T; Lauronen J; Raissadati A; Pihkala JI; Ylinen E; Puntila JT; Salminen JT; Pätilä T; Mattila IP; Jalanko HJ
Ann Transplant; 2019 Aug; 24():454-460. PubMed ID: 31383839
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
3. A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.
Michielsen LA; Wisse BW; Kamburova EG; Verhaar MC; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; van Zuilen AD
Nephrol Dial Transplant; 2019 Jun; 34(6):1056-1063. PubMed ID: 30365008
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival.
Irving C; Carter V; Parry G; Hasan A; Kirk R
Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210
[TBL] [Abstract][Full Text] [Related]
5. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the current post-transplantation Human Leukocyte Antigen antibody screening in pediatric renal transplant recipients.
Demirok A; Ranzijn C; Lardy J; Florquin S; Bouts A
Pediatr Transplant; 2019 Mar; 23(2):e13338. PubMed ID: 30635959
[TBL] [Abstract][Full Text] [Related]
7. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
8. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
[TBL] [Abstract][Full Text] [Related]
9. The Significance of Screening for HLA Antibodies in the Long-Term Follow-up of Pediatric Liver Transplant Recipients.
Tokodai K; Kawagishi N; Miyagi S; Nakanishi C; Hara Y; Fujio A; Kashiwadate T; Maida K; Goto H; Kamei T; Ohuchi N
Transplant Proc; 2016 May; 48(4):1139-41. PubMed ID: 27320574
[TBL] [Abstract][Full Text] [Related]
10. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.
Yang J; Schall C; Smith D; Kreuser L; Zamberlan M; King K; Gajarski R
J Heart Lung Transplant; 2009 Feb; 28(2):123-9. PubMed ID: 19201336
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
12. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-HLA antibodies associated with ventricular assist device use in pediatric patients: A United Network for Organ Sharing database analysis.
Magdo HS; Schumacher KR; Yu S; Gajarski RJ; Friedland-Little JM
Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28568969
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G subclass analysis of HLA donor specific antibodies in heart and renal transplant recipients.
Cicciarelli JC; Kasahara N; Lemp NA; Adamson R; Dembitsky W; Browne B; Steinberg S
Clin Transpl; 2013; ():413-22. PubMed ID: 25095537
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
17. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
18. Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection.
Jackups R; Canter C; Sweet SC; Mohanakumar T; Morris GP
J Clin Apher; 2013 Aug; 28(4):301-8. PubMed ID: 23426730
[TBL] [Abstract][Full Text] [Related]
19. Pre-transplant donor-specific anti-human leukocyte antigen antibodies are associated with high risk of delayed graft function after renal transplantation.
Peräsaari JP; Kyllönen LE; Salmela KT; Merenmies JM
Nephrol Dial Transplant; 2016 Apr; 31(4):672-8. PubMed ID: 26614272
[TBL] [Abstract][Full Text] [Related]
20. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
